Literature DB >> 5341843

The hypothalamic-pituitary-adrenocortical system. Clinical evaluation by pharmacologic techniques.

G Gwinup.   

Abstract

The hypothalamic-pituitary-adrenocortical system is a complex negative feed-back control mechanism. Under non-stress conditions it functions to maintain a circadian rhythm of adrenal steroid production which is secondary to a circadian fluctuation in the sensitivity to suppression of acth by hydrocortisone. Any stressful stimulus causes an augmentation of steroid production which is due in part to a decrease in sensitivity of acth to suppression. Aldosterone production is not primarily controlled by acth. The increased understanding of this system and of its pathologic alterations has led to the development of a number of pharmacologic techniques which have proved most valuable in evaluating its integrity. Hypothalamic-pituitary function can be assessed by the response to the administration of dexamethasone, methopyrapone, bacterial pyrogen and vasopressin. Adrenal cortical function can be assessed by the response to acth, dexamethasone and spironolactone.

Entities:  

Mesh:

Year:  1967        PMID: 5341843      PMCID: PMC1502765     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  11 in total

1.  DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS.

Authors:  T NICHOLS; C A NUGENT; F H TYLER
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

2.  Blood corticotropin (ACTH) levels in Cushing's disease.

Authors:  W C WILLIAMS; D ISLAND; R A OLDFIELD; G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1961-04       Impact factor: 5.958

3.  Adrenocorticotrophic activity in the plasma of patients with Cushing's syndrome associated with pulmonary neoplasms.

Authors:  N P CHRISTY
Journal:  Lancet       Date:  1961-01-14       Impact factor: 79.321

4.  Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome.

Authors:  G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1960-12       Impact factor: 5.958

5.  Clinical application of a new test of pituitary reserve.

Authors:  G W LIDDLE; H L ESTEP; J W KENDALL; W C WILLIAMS; A W TOWNES
Journal:  J Clin Endocrinol Metab       Date:  1959-08       Impact factor: 5.958

6.  Cause of Cushing's syndrome in patients with tumors arising from "nonendocrine" tissue.

Authors:  C K MEADOR; G W LIDDLE; D P ISLAND; W E NICHOLSON; C P LUCAS; J G NUCKTON; J A LUETSCHER
Journal:  J Clin Endocrinol Metab       Date:  1962-07       Impact factor: 5.958

7.  Plasma ACTH determinations in 58 patients before or after adrenalectomy for Cushing's syndrome.

Authors:  D H Nelson; J G Sprunt; R B Mims
Journal:  J Clin Endocrinol Metab       Date:  1966-07       Impact factor: 5.958

8.  Studies on the mechanism of vasopressin-induced steroid secretion in man.

Authors:  G Gwinup
Journal:  Metabolism       Date:  1965-12       Impact factor: 8.694

9.  A rapid test for adrenocortical insufficiency.

Authors:  D E Maynard; R L Folk; T R Riley; R G Wieland; G Gwinup; G J Hamwi
Journal:  Ann Intern Med       Date:  1966-03       Impact factor: 25.391

10.  Test for pituitary function using vasopressin.

Authors:  G Gwinup
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.